Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
07 2020
Historique:
received: 23 06 2019
accepted: 09 04 2020
pubmed: 16 4 2020
medline: 31 12 2020
entrez: 16 4 2020
Statut: ppublish

Résumé

T cells isolated from the pancreatic infiltrates of nonobese diabetic mice have been shown to recognize epitopes formed by the covalent cross-linking of proinsulin and secretory granule peptides. Formation of such hybrid insulin peptides (HIPs) was confirmed through mass spectrometry, and responses to HIPs were observed among the islet-infiltrating T cells of pancreatic organ donors and in the peripheral blood of individuals with type 1 diabetes (T1D). However, questions remain about the prevalence of HIP-specific T cells in humans, the sequences they recognize, and their role in disease. We identified six novel HIPs that are recognized in the context of DRB1*04:01, discovered by using a library of theoretical HIP sequences derived from insulin fragments covalently linked to one another or to fragments of secretory granule proteins or other islet-derived proteins. We demonstrate that T cells that recognize these HIPs are detectable in the peripheral blood of subjects with T1D and exhibit an effector memory phenotype. HIP-reactive T-cell clones produced Th1-associated cytokines and proliferated in response to human islet preparations. These results support the relevance of HIPs in human disease, further establishing a novel posttranslational modification that may contribute to the loss of peripheral tolerance in T1D.

Identifiants

pubmed: 32291282
pii: db19-0620
doi: 10.2337/db19-0620
pmc: PMC7306133
doi:

Substances chimiques

Epitopes 0
HLA-DRB1 Chains 0
HLA-DRB1*04:01 antigen 0
Insulin 0
Peptide Fragments 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1492-1502

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK081166
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI133059
Pays : United States

Informations de copyright

© 2020 by the American Diabetes Association.

Références

J Autoimmun. 2017 Mar;78:11-18
pubmed: 27802879
J Exp Med. 2018 Oct 1;215(10):2617-2635
pubmed: 30185635
J Allergy Clin Immunol. 2010 Jun;125(6):1407-1409.e1
pubmed: 20513526
Curr Diab Rep. 2015 Nov;15(11):90
pubmed: 26370701
Diabetes. 2014 Jan;63(1):237-47
pubmed: 24089515
Arthritis Rheumatol. 2019 Apr;71(4):518-528
pubmed: 30390384
PLoS One. 2014 Nov 18;9(11):e112882
pubmed: 25405480
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14840-5
pubmed: 25267644
Arthritis Rheumatol. 2014 Jul;66(7):1712-22
pubmed: 24665079
Genes Immun. 2010 Mar;11(2):188-93
pubmed: 20054344
Diabetes. 2018 Jul;67(7):1356-1368
pubmed: 29654212
J Immunol. 2007 Jun 1;178(11):7032-41
pubmed: 17513752
Int Immunol. 2013 Aug;25(8):447-57
pubmed: 23524391
Diabetes. 2017 Mar;66(3):722-734
pubmed: 27920090
Cell Immunol. 2019 Jan;335:68-75
pubmed: 30428974
Nat Med. 2016 Dec;22(12):1482-1487
pubmed: 27798614
Diabetes. 2018 Sep;67(9):1836-1846
pubmed: 29976617
Science. 2016 Feb 12;351(6274):711-4
pubmed: 26912858
J Exp Med. 1999 May 17;189(10):1531-44
pubmed: 10330432
Nat Commun. 2016 Aug 30;7:12614
pubmed: 27571776
Cold Spring Harb Perspect Med. 2012 Apr;2(4):a007781
pubmed: 22474615
Clin Exp Immunol. 2007 Apr;148(1):1-16
pubmed: 17349009
J Immunol. 2004 May 15;172(10):5967-72
pubmed: 15128778
Diabetes. 2017 Dec;66(12):3051-3060
pubmed: 28842400
J Exp Med. 2005 Nov 7;202(9):1191-7
pubmed: 16260488
J Immunol. 1998 Mar 1;160(5):2365-73
pubmed: 9498778
J Proteome Res. 2019 Mar 1;18(3):814-825
pubmed: 30585061
Diabetes. 2019 Sep;68(9):1830-1840
pubmed: 31175101
Nature. 2005 May 12;435(7039):220-3
pubmed: 15889095
Sci Immunol. 2018 Feb 2;3(20):
pubmed: 29429978
Immunology. 2013 Mar;138(3):269-79
pubmed: 23228173
Diabetes. 2018 Jun;67(6):1035-1042
pubmed: 29784651
Nat Med. 2017 Apr;23(4):501-507
pubmed: 28263308
Diabetes. 2014 Sep;63(9):3033-40
pubmed: 24705406
J Immunol. 2012 Mar 15;188(6):2537-44
pubmed: 22327072
Diabetes. 2008 Apr;57(4):1084-92
pubmed: 18252895

Auteurs

David Arribas-Layton (D)

Benaroya Research Institute at Virginia Mason, Seattle, WA.

Perrin Guyer (P)

Benaroya Research Institute at Virginia Mason, Seattle, WA.

Thomas Delong (T)

Department of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Denver, CO.

Mylinh Dang (M)

Department of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Denver, CO.

I-Ting Chow (IT)

Benaroya Research Institute at Virginia Mason, Seattle, WA.

Cate Speake (C)

Benaroya Research Institute at Virginia Mason, Seattle, WA.

Carla J Greenbaum (CJ)

Benaroya Research Institute at Virginia Mason, Seattle, WA.
Department of Medicine, University of Washington, Seattle, WA.

William W Kwok (WW)

Benaroya Research Institute at Virginia Mason, Seattle, WA.
Department of Medicine, University of Washington, Seattle, WA.

Rocky L Baker (RL)

Department of Immunology and Microbiology, University of Colorado School of Medicine, Denver, CO.

Kathryn Haskins (K)

Department of Immunology and Microbiology, University of Colorado School of Medicine, Denver, CO.

Eddie A James (EA)

Benaroya Research Institute at Virginia Mason, Seattle, WA ejames@benaroyaresearch.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH